This application note describes a miniaturized, semi-automated RNA-seq workflow combining direct cell lysis and nanoliter liquid handling to enable high-throughput gene expression profiling. The approach captures both coding and non-coding RNA, reduces rRNA background, and supports scalable, cost-efficient lead screening and prioritization in early drug development.